Cargando…
Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis
COVID-19 patients with acute hypoxemic respiratory failure (AHRF) benefit from high flow nasal cannula (HFNC) oxygen therapy. However, delays in initiating invasive ventilation after HFNC failure are associated with poorer outcomes. The respiratory oxygenation (ROX) index, combining SpO(2)/FiO(2) an...
Autores principales: | Yau, Chun En, Lee, Dawn Yi Xin, Vasudevan, Adithi, Goh, Ken Junyang, Wong, Evelyn, Ho, Andrew Fu Wah, Lim, Daniel Yan Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441756/ https://www.ncbi.nlm.nih.gov/pubmed/37605238 http://dx.doi.org/10.1186/s13054-023-04567-7 |
Ejemplares similares
-
Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate
por: Goh, Ken Junyang, et al.
Publicado: (2020) -
Predicting Outcomes of High-Flow Nasal Cannula for Acute Respiratory Distress Syndrome. An Index that ROX
por: Hill, Nicholas S., et al.
Publicado: (2019) -
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure
por: Lemiale, Virginie, et al.
Publicado: (2021) -
Correction to: Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure
por: Lemiale, Virginie, et al.
Publicado: (2021) -
The value of ROX index in predicting the outcome of high flow nasal cannula: a systematic review and meta-analysis
por: Junhai, Zhen, et al.
Publicado: (2022)